<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2938833/" ref="ordinalpos=2679&amp;ncbi_uid=2987785&amp;link_uid=PMC2938833" image-link="/pmc/articles/PMC2938833/figure/f2/" class="imagepopup">FIG. 2. From: The Actin-Cytoskeleton <span class="highlight" style="background-color:">Pathway</span> and Its Potential Role in Inflammatory Bowel Disease-Associated Human Colorectal Cancer. </a></div><br /><div class="p4l_captionBody">The actin-cytoskeleton signaling pathway and the candidate genes involved in colorectal cancer progression in patients with ulcerative colitis. FGF-2, Pfn-2, Rdx, and Abi-2 are up-regulated (black). DIAPH1/DRF1 is down-regulated (light gray). FGF-2, fibroblast growth factor-2; Pfn-2, profilin-2; Rdx, radixin; Abi-2, Abelson interactor-2; DIAPH1, diaphanous homolog.</div></div>